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Utilization characteristics from a managed commercial health
plan with a 3-tier beneﬁt design were used for comparison. Pre-
scription utilization data statistics such as per member per month
costs and utilization and types of drug used were calculated. The
top ﬁve therapeutic classes ranked by drug cost per member per
month were also identiﬁed and compared. RESULTS: Mail order
penetration was 5.9% with Medicare and 3.6% for commercial
businesses. Mean age of pharmacy utilizers was 73.1 and 50.6
years in Medicare and commercial business, respectively. Generic
utilization was lower for mail order versus retail pharmacies
(46.9% and 54.8% for Medicare and 34.8% and 46.2% for
commercial business, respectively). Prescription volume was 30.8
and 9.4 per member per year in Medicare and commercial busi-
ness, respectively. Mean ingredient cost was lower in Medicare
plans ($43.79 versus $56.68 in commercial business), while
mean copay was higher in Medicare plans ($27.92 versus $20.08
in commercial business). The top therapeutic classes, as ranked
by ingredient cost per member per month, were similar for both
Medicare and commercial businesses. For Medicare business, the
top classes were antihyperlipidemics, antihypertensives, ulcer
drugs, and antidiabetic agents. For commercial business the top
classes were antihyperlipidemics, ulcer drugs, antidepressants,
and antidiabetic agents. CONCLUSIONS: Prescription utiliza-
tion patterns and drug mix for members in Medicare programs
and commercial health plans differed, mainly driven by beneﬁt
design and coverage policy. Understanding of these differences
are essential to effective Medicare pharmacy program design.
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OBJECTIVE: The objective of the current study is to determine
number and the speciﬁcity of risk factors (side effects, speciﬁc
side effects, contra indications, total number of sentences) dis-
closed in a typical direct-to-consumer print advertisement pub-
lished in 2002. METHODS: Content analysis is a research
technique for the systematic classiﬁcation and description of
communication content to certain usually predetermined cate-
gories. All product speciﬁc prescription drug advertisements
appearing in seven consumer magazines from January 2002 to
December 2002 were collected. The sampling of magazines was
purposive. The magazines were selected based upon their circu-
lation and appeal. All the four variables were deﬁned explicitly.
Side effects were deﬁned as any unwarranted secondary and
adverse effects of the drug. Speciﬁc side effects were deﬁned as
those side effects, which were stressed upon, and where more
information was provided. Contraindications were deﬁned as
statements that contraindicate the use of the advertised drug in
speciﬁc populations or situations. The total number of sentences
was deﬁned as the total number of sentences in the print adver-
tisement that contained any of the side effects, speciﬁc side effects
or contraindications. Judges were trained to determine the valid-
ity of operational guidelines. Cohen’s Kappa was used to deter-
mine inter-rater agreement. Each brand name drug advertisement
served as the unit of analysis. Descriptive statistics were the
primary tool for analytical procedures. RESULTS: A total of 349
advertisements were identiﬁed which represented 40 distinct
brand drugs. There was an average of 4.6 side effects per adver-
tisement. Of these, 0.7 speciﬁc side effects were mentioned per
advertisement. Each advertisement contained an average of 1.7
contraindications and 2.55 sentences. CONCLUSION: Adver-
tisements contained only an average of 2.55 risk statements. The
average number of side effects disclosed in a typical advertise-
ment is less than ﬁve. More than half of the advertisements did
not mention speciﬁc side effects.
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OBJECTIVES: The objective of this study was to investigate the
factors inﬂuencing the relationship between Health Locus of
Control (HLC) and consumer responsiveness to Direct-to-Con-
sumer advertising (RDTCA) of generic and brand name pre-
scription drugs. This study was intended to provide a framework
to aid in the promotion of generic utilization by consumers and
better targeting of consumers by DTC advertisements in a more
cost-efﬁcient manner, thereby reducing health care expenditure.
METHODS: Direct-mail survey was employed for the purpose
of this study, and questionnaires were sent to a simple random
sample of 900 individuals taken from the entire population of
the United States. The survey was designed according to
Dillman’s Total Design Method, and consisted of several vali-
dated scales, such as the Wallston multidimensional HLC scale,
the Health Value scale by Lau et al, some items seeking to estab-
lish consumer RDTCA, and demographic items. RESULTS: A
net response rate of 47.33% was obtained. Regression tech-
niques and ANOVA were the primary statistical tests employed
to address the research questions. The results established that
RDTCA of brand name prescription drugs was signiﬁcantly
related to External HLC orientation, educational level, income,
gender, race and presence of health insurance. The analysis also
showed the existence of statistically signiﬁcant relationships
between RDTCA of generics and educational level, income,
gender and presence of health insurance. The study suggests that
RDTCA of prescription drugs decreases as the level of both edu-
cation and household income increases, and that females are
more likely to respond to DTC advertising. CONCLUSIONS:
Consumer responsiveness to DTC advertising of prescription
drugs can serve as the basis for well-directed DTC campaigns at
target populations. The results provide several variables that can
be used as the basis for market segmentation, which can be useful
for DTC advertising of both brand name and generic prescrip-
tion drugs.
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OBJECTIVE: The objective of this research was to examine the
relationship between ﬁnancial valuation and both ﬁrm- and
industry-speciﬁc measures of technological change for ﬁrms
